Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
Donanemab (anti-Amyloid Beta) - Primary antibody, specific to APP, >95%, high purity, Human IgG1, DISRUPTING AGENT of Beta amyloid A4 protein disrupting agent, DISRUPTING AGENT of Beta amyloid A4 protein disrupting agent
- Host species: Human
- Reactive species: Human
- Isotype: Human IgG1
- Conjugation: Unconjugated
In stock
Item Number
Ab175512
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab175512-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$69.90
|
|
|
Ab175512-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$329.90
|
|
|
Ab175512-5mg
|
5mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$869.90
|
|
|
Ab175512-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,379.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated